CAS 105816-04-4
:Nateglinid
- AY 4166
- N-[[trans-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
- D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-
- D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, trans-
- A 4166
Nateglinide
CAS:Formel:C19H27NO3Reinheit:>98.0%(T)(HPLC)Farbe und Form:White to Almost white powder to crystalMolekulargewicht:317.43NATEGLINIDE CRS
CAS:NATEGLINIDE CRSFormel:C19H27NO3Farbe und Form:White. Powder.Molekulargewicht:317.4226Nateglinide
CAS:Aromatic cyclic amides (including cyclic carbamates) anFormel:C19H27NO3Farbe und Form:White PowderMolekulargewicht:317.19909(2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
CAS:Formel:C19H27NO3Reinheit:99%Farbe und Form:SolidMolekulargewicht:317.4226Nateglinide
CAS:Formel:C19H27NO3Reinheit:≥ 98.0%Farbe und Form:White to off-white powderMolekulargewicht:317.42Nateglinide
CAS:Nateglinide is an oral drug for type 2 diabetes, stimulating insulin release; may cause rare acute liver injury.Formel:C19H27NO3Reinheit:99.93% - 99.94%Farbe und Form:White Crystalline PowderMolekulargewicht:317.42Nateglinide
CAS:Kontrolliertes ProduktApplications An amino-acid derivative that stimulates insulin secretion. Used as an antidiabetic.
References Shinkai, H., et al.: J. Med. Chem., 32, 1436 (1989), Sato, Y., et al.: Diabetes Res. Clin. Pract., 12, 53 (1991), Vicent, D., et al.: J. Clin. Invest., 111, 1373 (2003), Ceriello, A., et al.: Diabet. Med., 21, 171 (2004),Formel:C19H27NO3Farbe und Form:White To Off-WhiteMolekulargewicht:317.42Nateglinide - Bio-X ™
CAS:Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.Formel:C19H27NO3Reinheit:Min. 95%Molekulargewicht:317.42 g/molNateglinide
CAS:Nateglinide is used to treat type 2 diabetes mellitus as an oral hypoglycemic, insulinotropic agent. It is a blocker of ATP-dependent potassium channels and works by increasing the body's production of insulin, which lowers blood glucose levels. Nateglinide has been shown to be effective in reducing postprandial blood glucose levels in patients with type 2 diabetes who have not responded well to other treatments. The effects of nateglinide are reversible.
Formel:C19H27NO3Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:317.42 g/molRef: 3D-FN26165
Ausgelaufenes produkt














